Friday, August 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Zynex Q4 Earnings Report Analysis and Outlook

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Healthcare cloud based
0
SHARES
19
VIEWS
Share on FacebookShare on Twitter

Zynex, a publicly traded company on the NASDAQ under the ticker symbol ZYXI, recently shared its Q4 earnings report, providing valuable insights for investors to consider:

Earnings Performance:
Surprisingly, Zynex fell short of the estimated earnings by a significant margin of -76.0%, with an EPS of $0.04 compared to the expected $0.17.
Additionally, the company experienced a decrease in revenue of $1.52 million compared to the same period last year.

Past Earnings Performance:
In the previous quarter, Zynex surpassed EPS estimates by $0.01, resulting in a 17.0% increase in share price the following day.
To provide a comprehensive view of Zynex’s performance, here is a summary of their past earnings:
– Q3 2023: EPS Estimate $0.09, EPS Actual $0.10, Revenue Estimate $49.87 million, Revenue Actual $49.91 million
– Q2 2023: EPS Estimate $0.04, EPS Actual $0.09, Revenue Estimate $44.65 million, Revenue Actual $44.95 million
– Q1 2023: EPS Estimate $0.01, EPS Actual $0.04, Revenue Estimate $39.61 million, Revenue Actual $42.17 million
– Q4 2022: EPS Estimate $0.19, EPS Actual $0.20, Revenue Estimate $49.71 million, Revenue Actual $48.80 million

Upcoming Events:
Investors can mark their calendars for Zynex’s next earnings call, scheduled for Thursday, February 29, 2024, from 4:15 PM to 5:15 PM EST, where the company will discuss its performance for the fourth quarter and full year of 2024.

For more in-depth information and to stay updated on all earnings releases from Zynex, investors are encouraged to visit the company’s official website or financial platforms such as Nasdaq and TipRanks.

ZYXI Stock Analysis: Promising Performance on February 29, 2024

On February 29, 2024, ZYXI stock showed promising performances as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been on an upward trend and is considered to be in a bullish position. The price of ZYXI shares increased by $0.07 since the market last closed, representing a 0.52% rise. The stock closed at $13.56, showing a positive movement during regular trading hours. However, in after-hours trading, the stock dropped by $1.55. Despite the drop in after-hours trading, the overall performance of ZYXI stock on February 29, 2024, reflects a positive trend. Investors may want to keep an eye on the stock in the coming days to see if it continues its upward momentum or if there are any fluctuations in price.

ZYXI Stock Analysis: Strong Revenue Growth and Profitability Signals Positive Trajectory in Healthcare Sector

On February 29, 2024, ZYXI stock showed promising performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was reported at $158.17 million, which represented a 21.39% increase compared to the previous year. In the third quarter alone, ZYXI generated $49.91 million in total revenue, marking an 11.04% increase from the previous quarter.

Despite the impressive revenue growth, ZYXI’s net income remained relatively flat compared to the previous year, standing at $17.05 million. However, the company managed to increase its net income by 7.16% in the third quarter, reaching $3.59 million. This improvement in net income is a positive sign for investors, indicating that ZYXI is effectively managing its expenses and increasing profitability.

Earnings per share (EPS) also saw positive growth trends for ZYXI. The company reported an EPS of $0.44 for the past year, reflecting a 9.83% increase compared to the previous year. In the third quarter, ZYXI’s EPS reached $0.10, showing a 10.06% increase from the previous quarter. This growth in EPS suggests that ZYXI is effectively translating its revenue growth into higher earnings for its shareholders.

Overall, ZYXI’s financial performance on February 29, 2024, indicates a strong and positive trajectory for the company. With consistent revenue growth, improving net income, and increasing earnings per share, ZYXI stock is likely to attract investors looking for a promising investment opportunity in the healthcare sector. Investors should keep an eye on ZYXI’s future financial reports to track the company’s continued growth and profitability.

Tags: ZYXI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

Precision BioSciences Announces Public Offering of Common Stock and Warrants

Software-solutions-technology

Autodesks Optimistic Projections for Fiscal Year 2025

Software-solutions-technology

Verra Mobilitys Q4 Earnings Report Revenue Surpasses Expectations Earnings Growth Expected

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com